We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

122 hedge funds and large institutions have $75.9M invested in Esperion Therapeutics in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

398% more call options, than puts

Call options by funds: $1.67M | Put options by funds: $335K

16% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 31

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

5% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 22

2% less funds holding

Funds holding: 124122 (-2)

6.31% less ownership

Funds ownership: 78.54%72.23% (-6.3%)

27% less capital invested

Capital invested by funds: $104M → $75.9M (-$27.7M)

Holders
122
Holders Change
-2
Holders Change %
-1.61%
% of All Funds
1.94%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
21
Increased
36
Reduced
31
Closed
22
Calls
$1.67M
Puts
$335K
Net Calls
+$1.33M
Net Calls Change
+$231K
Name Holding Trade Value Shares
Change
Change in
Stake
WA
1
Wasatch Advisors
Utah
$11.3M -$2.33M -1,613,456 -12%
TSC
2
Two Seas Capital
New York
$7.52M +$6.84M +4,730,298 +161%
Millennium Management
3
Millennium Management
New York
$5.68M +$3.54M +2,447,303 +73%
Vanguard Group
4
Vanguard Group
Pennsylvania
$4.65M +$692K +478,097 +11%
BG
5
Bellevue Group
Switzerland
$4.12M -$5.79K -4,000 -0.1%
MG
6
Meditor Group
Bermuda
$3.72M -$885K -611,673 -14%
PIM
7
Platinum Investment Management
Australia
$3.13M -$405K -280,117 -8%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$3.04M -$2.72M -1,877,148 -38%
Jacobs Levy Equity Management
9
Jacobs Levy Equity Management
New Jersey
$2.22M +$2.66M +1,836,567 +429%
Morgan Stanley
10
Morgan Stanley
New York
$2.06M +$1.65M +1,138,359 +118%
PHP
11
Parkman Healthcare Partners
Connecticut
$1.96M -$196K -135,238 -6%
BlackRock
12
BlackRock
New York
$1.93M +$956K +660,427 +51%
JP Morgan Chase
13
JP Morgan Chase
New York
$1.83M +$2.37M +1,640,585 +733%
TCM
14
Tang Capital Management
California
$1.81M
IC
15
Ikarian Capital
Texas
$1.7M +$46.3K +32,031 +2%
Marshall Wace
16
Marshall Wace
United Kingdom
$1.54M +$1.82M +1,258,207 +398%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$1.51M +$1.23M +851,268 +124%
Two Sigma Investments
18
Two Sigma Investments
New York
$1.43M +$407K +281,087 +24%
SSA
19
Schonfeld Strategic Advisors
New York
$1.21M -$122K -84,273 -6%
Goldman Sachs
20
Goldman Sachs
New York
$1.15M +$508K +351,285 +43%
MAM
21
Monaco Asset Management
Monaco
$1.15M +$689K +476,477 +69%
GCP
22
GSA Capital Partners
United Kingdom
$1.09M +$992K +685,733 +159%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$951K +$212K +146,731 +18%
Citadel Advisors
24
Citadel Advisors
Florida
$639K -$79.9K -55,227 -8%
UOC
25
UBS O'Connor
Illinois
$619K +$485K +335,000 +113%